GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (LTS:0J4V) » Definitions » Float Percentage Of Total Shares Outstanding

Heron Therapeutics (LTS:0J4V) Float Percentage Of Total Shares Outstanding : 77.19% (As of Jun. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Heron Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Heron Therapeutics's float shares is 116.29 Mil. Heron Therapeutics's total shares outstanding is 150.65 Mil. Heron Therapeutics's float percentage of total shares outstanding is 77.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Heron Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Heron Therapeutics's Institutional Ownership is 29.48%.

Heron Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Heron Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=116.29/150.65
=77.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heron Therapeutics (LTS:0J4V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (LTS:0J4V) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ALT OABI TRDA ALLO LXEO CABA ADPT OLMA NWBO YMAB OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
HRTX:USA AXD2:Germany AXD2:Germany
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Website
https://www.herontx.com
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (LTS:0J4V) Headlines

No Headlines